Loading organizations...
IFSC is a direct lender specializing in heavy equipment financing for deals exceeding $100,000, primarily serving clients across the United States. The organization provides non-bank financing solutions designed to support capital expenditure and growth for businesses in over 25 diverse industries, ranging from large Fortune 500 corporations to emerging startups. With an operational history spanning more than 45 years in the equipment finance sector, IFSC has successfully funded over $1 billion in transactions. The firm's business model centers on generating revenue through interest and fees derived from its extensive loan portfolio. IFSC was established in 1981; specific founder names are not publicly disclosed. Its business model centers on direct lending for equipment financing, generating revenue through interest and fees on loans.
IFSC has 1 tracked investment across 1 company. The latest tracked deal is $60.0M Series B in Epigenic Therapeutics in September 2025.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Sep 1, 2025 | Epigenic Therapeutics | $60.0M Series B | Zhihua YU | OrbiMed, Qiming Venture Partners |